Back/Interwell Health Appoints Dr. Carney Taylor as CMO to Enhance Value-Based Kidney Care
health·January 24, 2026·fms

Interwell Health Appoints Dr. Carney Taylor as CMO to Enhance Value-Based Kidney Care

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Interwell Health, part of Fresenius Medical Care, appoints Dr. Carney Taylor as Chief Medical Officer to enhance kidney care.
  • Dr. Taylor aims to empower nephrologists and improve patient outcomes through innovative, value-based strategies at Interwell Health.
  • Interwell Health focuses on supporting nephrologists with resources to thrive in delivering high-quality, patient-centered kidney care.

Interwell Health Appoints Dr. Carney Taylor as Chief Medical Officer to Advance Value-Based Kidney Care

Interwell Health, a prominent entity in value-based kidney care and part of Fresenius Medical Care AG & Co. KGaA, announces the appointment of Dr. Carney Taylor, MD, MBA, as its new chief medical officer (CMO). This strategic move follows the retirement of Dr. George Hart, the former CMO, who will remain with the organization in an advisory capacity. Dr. Taylor's extensive experience in nephrology, spanning over 25 years, positions him as a strong leader to enhance Interwell's clinical strategy and drive initiatives aimed at improving physician engagement and care quality. His previous role as associate CMO and board member enables him to leverage his insights to further the company's mission.

Dr. Taylor emphasizes the importance of collaboration among nephrologists as essential to shaping Interwell's clinical direction. Currently, the organization partners with a network of 2,300 nephrologists who are crucial in implementing its innovative value-based care model. Dr. Taylor's leadership is expected to bolster these efforts by fostering a supportive environment for clinicians. His previous experience co-leading Eastern Nephrology Associates, one of the first practices to engage with Interwell and a significant participant in the federal value-based kidney care program, provides him with a unique perspective on the challenges and opportunities in this sector.

Under Dr. Taylor's stewardship, Interwell Health aims to expand its reach and enhance its innovative strategies to accommodate the growing population of kidney disease patients. The healthcare landscape is shifting, with payers increasingly favoring sustainable, physician-led approaches for managing high-risk patient populations. Dr. Taylor asserts that the secret to Interwell's success lies in empowering clinicians, which not only improves patient outcomes but also optimizes cost management for payers. By focusing on data-driven methodologies and utilizing specialized electronic health records, Interwell Health is committed to elevating patient care standards while also enhancing the practice experience for nephrologists.

In related developments, Interwell Health remains at the forefront of reshaping kidney care through its value-based model. The organization is dedicated to ensuring that nephrologists have the necessary resources and support to thrive in a complex healthcare environment.

As the company moves forward, the leadership transition marks a significant step in its ongoing commitment to delivering high-quality, patient-centered kidney care, setting a benchmark for the industry.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...